China

Munich Re taps new CEO for Beijing operations

He will succeed Steven Chang who will retire in March.

China to tighten medical insurance funds regulation with drug traceability codes

This aims to combat fraudulent activities like the resale of insured medications.

China’s medical insurance to deliver cheaper drugs

It has adjusted the insurance catalogue annually, now covering 3,159 drugs. 

China expands basic medical insurance portfolio

The country added 91 new drugs to its medical insurance drug catalogue.

Insurers expect China’s medical cost to increase 11% in 2025

Asia-Pacific is also slated to rise by 12.3% in 2025.

QHR Life Reinsurance drives strong underwriting: AM Best

The company’s capital and surplus increased by 4.3% to $500m in 2023.

Huize plans expansion in Singapore, Philippines

Its Q3 2024 gross written premiums (GWP) reached an all-time high of $290m.

China expands medical insurance drug catalogue to cover 90 rare disease

These treat conditions like hypertrophic cardiomyopathy, and intractable epilepsy.

Zheshang Insurance capital position under pressure: Fitch Ratings

Fitch also highlighted concerns over the insurer’s higher asset and liquidity risks.

AllianzGI gets greenlight to buy 2% Guomin Pension stake

It will subscribe to approximately 228 million newly issued shares.

China sets 5-year plan for property insurance

It includes attracting int’l financial institutions to invest in China's property insurance market.

Stable underwriting improves China Taiping Insurance's outlook

Capital and surplus increased by 2.4% in 2023, reaching $679m.

New action plan to advance China's digital finance sector by 2027

It focuses on digitalising financial institutions and leveraging data and technology.

China adds 91 drugs to national medical insurance list

The price of the newly included drugs will drop by an average of 63%.

JD Allianz, JD Auto enhance Dida’s insurance offerings

This synergises JD Auto and JD Allianz into Dida’s platform.

Taikang's robust capital to aid in business expansion: Fitch Ratings

Taikang Group’s profitability is supported by its value-driven business strategy.